VERAXA Biotech Advances Oncology Pipeline After NASDAQ Debut
VERAXA Biotech (NASDAQ: VRXA) advances its BiTAC oncology platform after NASDAQ debut, with preclinical data and key executive appointments. Explore the pipeline.
31 minutes ago
NewsRamp
Latest News
Greenland Mines Hails UN Security Pact, Boosts Critical Minerals
about 3 hours ago
Morph Brand Launches Vera Titanium Cookware with AeroGrid Tech
about 4 hours ago
MAX Power Mining Featured in AI Energy Editorial, Advances Natural Hydrogen
about 4 hours ago
Nightfood Holdings Featured in AINewsWire Editorial on Wafer Inspection Growth
about 4 hours ago
Knightscope Reports $27M in Renewals and New Business
about 5 hours ago
Greenland Mines Eyes Expanded Rare Earth Footprint in Greenland
about 5 hours ago
Uranium Energy to Report Fiscal 2026 Results on Sept. 29
about 5 hours ago
Tovel AI Launches Card Recorder With Mandatory Human Approval
about 5 hours ago
ROTH Hosts 5th Annual Healthcare Conference in NYC
about 5 hours ago
Tonix Expands TONMYA Medicare Coverage to 32M Lives, Sales Force to 150
about 5 hours ago
American Fusion Expands Patent Portfolio to 151, Eyes Uplisting
about 5 hours ago
HR News
Survale Launches Hiring Manager Candidate Experience Certification
about 6 hours ago
StevenDouglas Promotes Amanda Rassi to Lead National HR Search
about 7 hours ago
Emotional Skill Gap Summit: 4-Day Virtual Event for HR Leaders
4 days ago
Meeder Investment Management Appoints Mark Francher as CHRO
6 days ago
Law Firm Launches Employers Think Pink to Save Lives
6 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 days
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 days
VERAXA Biotech Advances Oncology Pipeline After NASDAQ Debut
31 minutes ago
Greenland Mines Hails UN Security Pact, Boosts Critical Minerals
about 3 hours ago
Morph Brand Launches Vera Titanium Cookware with AeroGrid Tech
about 4 hours ago
Crypto News
Crypto Lobbying Falls Short as Senate Blocks Clarity Act
about 5 hours ago
Forward Industries Adds 357K SOL, Holdings Hit 8.16M
about 6 hours ago
South Korea Faces Renewed Calls to Delay Crypto Tax
4 days ago
Crypto's Next Cycle: Infrastructure Over Price Charts
5 days ago
Hypercall Integrates Block Scholes Oracle Feeds for On-Chain Options
5 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 days
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 days
VERAXA Biotech Advances Oncology Pipeline After NASDAQ Debut
31 minutes ago
ROTH Hosts 5th Annual Healthcare Conference in NYC
about 5 hours ago
Tonix Expands TONMYA Medicare Coverage to 32M Lives, Sales Force to 150
about 5 hours ago
Technology News
VERAXA Biotech Advances Oncology Pipeline After NASDAQ Debut
31 minutes ago
MAX Power Mining Featured in AI Energy Editorial, Advances Natural Hydrogen
about 4 hours ago
Nightfood Holdings Featured in AINewsWire Editorial on Wafer Inspection Growth
about 4 hours ago
Knightscope Reports $27M in Renewals and New Business
about 5 hours ago
Uranium Energy to Report Fiscal 2026 Results on Sept. 29
about 5 hours ago
Events & Conferences
ROTH Hosts 5th Annual Healthcare Conference in NYC
about 5 hours ago
Helus Pharma CEO to Speak at TD Cowen Neuropsychiatry Summit
about 6 hours ago
CineDine: Twenty35 Agency's New Celebrity Supper Club Shines at TIFF 2026
about 12 hours ago
Brett A. Hurt to Discuss AI and Humanity at DFW Book Signing
about 12 hours ago
Ex-Bell Labs Innovator Launches Elite Enterprise Sales Workshop
about 12 hours ago
For newswires & publishers
We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
